Historical shareholding details of MORGAN STANLEY ASIA (SINGAPORE) PTE. - ODI holdings in Strides Pharma Science Ltd. (STAR)

Quarterly changes of MORGAN STANLEY ASIA (SINGAPORE) PTE. - ODI shareholding in Strides Pharma Science Ltd. over the previous quarters

Quarter Name Total no. shares held Percent Holding Pledged Locked
shares % shares %
Mar 2025 Morgan Stanley Asia (Singapore) Pte. - Odi 1,862,447 2.02% 0 0.00% 0 0.00%
Dec 2024 Morgan Stanley Asia (Singapore) Pte. - Odi 1,490,381 1.62% 0 0.00% 0 0.00%
Sep 2024 Morgan Stanley Asia (Singapore) Pte. - Odi 1,240,786 1.35% 0 0.00% 0 0.00%
Jun 2024 Morgan Stanley Asia (Singapore) Pte. - Odi 1,157,077 1.26% 0 0.00% 0 0.00%
Mar 2024 Morgan Stanley Asia (Singapore) Pte. - Odi 990,379 1.08% 0 0.00% 0 0.00%
Dec 2023 Morgan Stanley Asia (Singapore) Pte. - Odi 990,379 1.08% 0 0.00% 0 0.00%
Sep 2023 Morgan Stanley Asia (Singapore) Pte. - Odi 956,712 1.06% 0 0.00% 0 0.00%
Mar 2020 Morgan Stanley Asia (Singapore) Pte. 1,067,118 1.19% 0 0.00% 0 0.00%
Mar 2018 Morgan Stanley Mauritius Company Limited 1,341,407 1.50% 0 0.00% 0 0.00%
Dec 2017 Morgan Stanley Mauritius Company Limited 1,586,975 1.77% 0 0.00% 0 0.00%
Sep 2017 Morgan Stanley Asia (Singapore) Pte 1,135,304 1.27% 0 0.00% 0 0.00%
Sep 2017 Morgan Stanley Mauritius Company Limited 2,749,872 3.07% 0 0.00% 0 0.00%
Jun 2017 Morgan Stanley Asia (Singapore) Pte 1,208,464 1.35% 0 0.00% 0 0.00%
Jun 2017 Morgan Stanley Mauritius Company Limited 2,749,872 3.07% 0 0.00% 0 0.00%
Mar 2017 Morgan Stanley Asia (Singapore) Pte 1,909,437 2.14% 0 0.00% 0 0.00%
Mar 2017 Morgan Stanley Mauritius Company Limited 2,695,372 3.01% 0 0.00% 0 0.00%
Dec 2016 Morgan Stanley Asia (Singapore) Pte. 2,660,673 2.98% - -% - -%
Sep 2016 Morgan Stanley Asia (Singapore) Pte. 2,660,173 2.98% - -% - -%
Jun 2016 Morgan Stanley Asia (Singapore) Pte. 2,729,648 3.05% - -% - -%
Mar 2016 Morgan Stanley Asia (Singapore) Pte. 2,729,648 3.06% - -% - -%
Dec 2015 Morgan Stanley Asia (Singapore) Pte. 3,257,613 3.65% - -% - -%

View all shareholdings details of Strides Pharma Science Ltd.